Epsilon Healthcare Limited announced that effective immediately 21 November 2023, terminates Mr. Peter Giannopoulos as the role of the Chief Executive Officer. Mr. Giannopoulos did not complete his probationary period. This decision aligns with the terms and conditions outlined in the employment contract, specifically regarding the clause Probation.

In the interim, Mr. Daniel Sanghera, General Manager at Epsilon Pharma will become the interim CEO.